Stock Earnings

Question 1

NervGen Pharma Corp 的关键财务报表是什么？

Accepted Answer

根据最新的财务报表（Form-10K），NervGen Pharma Corp 的总资产为 $0，净loss为 $-24

Question 2

NGENF 的关键财务比率是什么？

Accepted Answer

NervGen Pharma Corp 的流动比率是 0，净利 margin 为 0，每股销售为 $0。

Question 3

NervGen Pharma Corp 的收入按细分市场或地理位置如何划分？

Accepted Answer

Currently NervGen Pharma Corp data is not available.

Question 4

NervGen Pharma Corp 是否盈利？

Accepted Answer

no，根据最新的财务报表，NervGen Pharma Corp 的净loss为 $-24

Question 5

NervGen Pharma Corp 有负债吗？

Accepted Answer

no，NervGen Pharma Corp 的负债为 0

Question 6

NervGen Pharma Corp 的流通股有多少？

Accepted Answer

NervGen Pharma Corp 的总流通股为 0

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	11	9	9	6	5	5
Research & Development	14	15	7	16	6	6
Operating Expenses	26	24	17	23	12	11
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-26	-24	-22	-20	-12	-11
Income Tax Expense	--	--	--	0	--	--
Net Income	-26	-24	-22	-20	-12	-11
Net Income Growth	13%	9%	10%	67%	9%	22%
Shares Outstanding (Diluted)	71.95	67.32	59.29	52.64	39.28	32.11
Shares Change (YoY)	3%	14%	13%	34%	22%	24%
EPS (Diluted)	-0.38	-0.35	-0.37	-0.39	-0.32	-0.34
EPS Growth	19%	-6%	-4%	22%	-7%	-8%
Free Cash Flow	-17	-16	-11	-17	-8	-6
Free Cash Flow Per Share	-0.23	-0.23	-0.18	-0.32	-0.2	-0.18
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-26	-24	-17	-23	-12	-11
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-26	-24	-17	-23	-12	-11
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	0%	--	--

NervGen Pharma Corp (NGENF) Price